The healing effect of Lactobacillus plantarum isolated from Iranian traditional cheese on gastric ulcer in rats

African Journal of Pharmacy and Pharmacology

Volumn 5, Issue 12, 2011, Pages 1446-1451

  Nasrabadi, Mitra Heydari ^a   Aboutalebi, Helia ^a   Ebrahimi, Maryam Tajabadi ^b   Zahedi, Farima ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Gastric ulcer; Healing; Lactobacillus plantarum; Probiotic

Indexed keywords

COLLAGEN; LACTIC ACID; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM ISOLATION; CHEESE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FIBROBLAST; HISTOPATHOLOGY; IMMUNOSTIMULATION; LACTOBACILLUS PLANTARUM; MACROPHAGE; MALE; NEUTROPHIL COUNT; NONHUMAN; RAT; STOMACH ULCER; ULCER HEALING;

EID: 80054859171     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: 10.5897/AJPP11.155     Document Type: Article

References (36)

1. Bauer R, Bekker J, van Wyk N, Du Toit Ch, Dicks L, Kossmann J (2009). Exopolysaccharide production by lactose-hydrolyzing bacteria isolated from traditionally fermented milk. Int. J. Food. Microbiol., 131: 260-264.
2. Bing SR, Kinouchi T, Kataoka K, Kuwahara T, Ohnishi Y (1998). Protective effects of a culture supernatant of Lactobacillus acidophilus and antioxidants on ileal ulcer formation in rats treated with a nonsteroidal anti-inflammatory drug. Microbiol. Immunol., 42: 745-753.
3. Chabot S, Yu HL, Leseleuc L De, Cloutier D, Van Calsteren MR, Roy D, Lacroix M, Oth D (2001). Exopolysaccharides from Lactobacillus rhamnosus RW-9595M stimulate TNF, IL-6 and IL-12 in human and mouse cultured immune competant cells and IFN-g in mouse splenocytes. Lait., 81: 683-687.
4. Chapat L, Chemin K, Dubois B, Bourdet-Sicard R, Kaiserlian D (2004). Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. Eur. J. Immunol., 34: 2520-2528.
5. Desai KM, Akolkar SK, Badhe YP, Tambe SS, Lele SS (2006). Optimization of fermentation media for exopolysaccharide production from Lactobacillus plantarum using artificial intelligence-based techniques. Proc. Biochem., 41: 1842-1848.
6. DeVuyst L, Degeest B (1999). Heteropolysaccharides from lactic acid bacteria. FEMS. Microbiol. Rev., 23: 153-177.
7. Diegelmann R, Evans MC (2004). Wound healing: an overview of acute, fibrotic and delayed healing. Front. Biosci., 9: 283-289.
8. Ebrahimi TM, Ouwehand AC, Hejazi MA, Jafari P (2011). Traditional Iranian dairy products: A source of potential probiotic lactobacilli. Afr. J. Microbiol. Res., 5: 20-27.
9. Eswara Murali S, Kavitha BTVV, Srikanth JG, Velmani G (2010). Probiotics as Potential Therapies in Human Gastrointestinal Health. Int. J. Adv. Pharmaceutical. Sci., 1: 96-110.
10. Gotteland M, Brunser O, Cruchet S (2006). Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment. Pharmacol. Ther., 3: 1077-1086.
11. Halper J, Leshin LS, Lewis SJ, Li WI (2003). Wound healing and angiogenic properties of supernatants from Lactobacillus cultures. Exp. Biol. Medicine (Maywood). 228: 1329-1337.
12. Hausmann M (2010). How Bacteria-Induced Apoptosis of Intestinal Epithelial Cells Contributes to Mucosal Inflammation. Int. J. Inflamm., pp. 1-9.
13. Hegazy SK, El-Bedewy MM (2010). Effect of probiotics on proinflammatory cytokines and NF-κB activation in ulcerative colitis. World J. Gastroenterol., 16: 4145-4151.
14. Herich R, Levkut M (2002). Lactic acid bacteria, probiotics and immune system. Vet. Med. Czech, 47: 169-180.
15. Korakli M, Vogel RF (2006). Structure/function relationship of homopolysaccharide producing glycansucrases and therapeutic potential of their synthesised glycans. Appl. Microbiol. Biotechnol., 71: 790-803.
16. Lam EK, Woo PC, Cho CH (2005). Probiotics and gastrointestinal disorders. Pharmacology (Online). 1: 88-147.
17. Lam EK, Yu L, Wong HP, Wu WK, Shin VY, Tai EK, So WH, Woo PC, Cho CH (2007). Probiotic Lactobacillus rhamnosus GG enhances gastric ulcer healing in rats. Eur. J. pharmacol., 565: 171-179.
18. Levander F, Rådström P (2001). Requirement for phosphoglucomutase in exopolysaccharide biosynthesis in glucose- and lactose-utilizing Streptococcus thermophilus. Appl. Env. Microbiol., 67: 2734-2738.
19. Ma L, Chow JY, Cho CH (1999). Cigarette smoking delays ulcer healing: role of constitutive nitric oxide synthase in rat stomach. Am. J. Physiol. Gasterointest. Liver Physiol., 276: G238-G248.
20. Nagaoka M, Hashimito S, Watanabe T, Yokokura T, Mori T (1994). Antiulcer effects of lactic acid bacteria and their cell wall polysaccharides. Biol. Pharm. Bull., 17: 1012-17.
21. Nakajima H, Suzuki Y, Kaizu H, Hirota T (1992). Cholesterol lowering activity of ropy fermented milk. J. Food. Sci., 57: 1327-1329.
22. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL (2000). Prokaryotic regulation of epithelial responses by inhibition of IkappaB alpha ubiquitination. Science, 289: 1560-1563.
23. Ng SC, Hart AL, Kamm AM, Stagg AJ, Knight SC (2009). Mechanisms of Action of Probiotics: Recent Advances. Inflamm. Bowel. Dis., 15: 300-310.
24. Oda M, Hasegawa H, Komatsu S, Kambe M, Tsuchiya F (1983). Antitumor polyaschharide from Lactobacillus sp. Agric. Boil. Chem., 47: 1623-1625.
25. Ogueke CC, Owuamanam CI, Ihediohanma NC, Iwouno JO (2010). Probiotics and Prebiotics: Unfolding Prospects for Better Human Health. Pak. J. Nutr., 9: 833-843.
26. Olusegun AO, Iniobong GN (2011). Spoilage and preservation of meat: a general appraisal and potential of lactic acid bacteria as biological preservatives. Int. Res. J. Biotechnol., 2: 033-046.
27. Pathmakanthan S, Li CK, Cowie J, Howkey CJ (2004). Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamedhuman colon. J. Gastroenterol. Hepatol., 19: 166-173.
28. Resta-Lenert S, Barrett KE (2003). Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut., 52: 988-997.
29. Saxelin M, Tynkkynen S, Mattila-Sandholm T, De Vos Willem M (2005). Probiotic and other functional microbes: from markets to mechanisms. Curr. Opin. Biotechnol., 16: 204-211.
30. Schiraldi C, Valli V, Molinaro A, Carteni M, De Rosa M (2006). Exopolysaccharides production in Lactobacillus bulgaricus and Lactobacillus casei exploiting microfiltration. J. Ind. Microbiol. Biotechnol., 33: 384-390.
31. Svensson M, Waak E, Svensson U, Rådström P (2005). Metabolically improved exopolysaccharide production by Streptococcus thermophilus and its influence on the rheological properties of fermented milk. Appl. Env. Microbiol., 71: 6398-6400.
32. Tarnawski AS (2005). Cellular and molecular mechanisms of ulcer healing, Lessons from gastrointestinal ulcers. Department of medicine, University of California, Irvine, California, USA. pp. 1-12.
33. Uchida M, Kurakazu K (2004). Yogurt containing Lactobacillus gasseri OLL2716 exerts gastroprotective action against acute gastric lesion and antral ulcer in rats. J. Pharmacol. Sci., 96: 84-90.
34. Valdez JC, Peral MC, Rachid M, Santana M, Perdigon G (2005). Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment. Clin. Microbiol. Infect., 11: 472-479.
35. Vinderola G, Perdigón G, Duarte J, Farnworth E, Matar CH (2006). Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity. Cytokine, 36: 254-260.
36. Yan F, Polk DB (2002). Probiotic bacterium prevents cytokine-induced apoptosisin intestinal epithelial cells. J. Biol. Chem., 277: 50959-50965.